Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) Not A Good Play Anymore?
Sonoma Pharmaceuticals Inc. (SNOA) concluded trading on Wednesday at a closing price of $0.16, with 2.99 million shares of worth about $0.48 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 13.62% during that period and on August 28, 2024 the price saw a […]
There Is Clear Momentum For Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA)
Sonoma Pharmaceuticals Inc. (SNOA) concluded trading on Wednesday at a closing price of $0.22, with 18.24 million shares of worth about $4.01 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 43.85% during that period and on August 21, 2024 the price saw a […]
Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) Not A Good Play Anymore?
Sonoma Pharmaceuticals Inc. (SNOA) concluded trading on Thursday at a closing price of $0.35, with 28.63 million shares of worth about $10.02 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 92.88% during that period and on July 11, 2024 the price saw a […]
Tomorrow Is Not Likely To Be Same For Sonoma Pharmaceuticals Inc. (SNOA)
Sonoma Pharmaceuticals Inc. (SNOA) concluded trading on Wednesday at a closing price of $0.27, with 10.47 million shares of worth about $2.83 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 48.41% during that period and on Wednesday the price saw a gain of […]
Investors Should Take Note Of Sonoma Pharmaceuticals Inc. (SNOA)
Sonoma Pharmaceuticals Inc. (SNOA) concluded trading on Wednesday at a closing price of $0.19, with 52.57 million shares of worth about $9.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -82.54% during that period and on Wednesday, January 31 the price saw a […]
Reviewing The Case For Sonoma Pharmaceuticals Inc. (SNOA) Going Higher
Tower Research Capital LLC recently announced the acquisition of new stake in Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA). The institutional investor has increased its shareholding in the Healthcare company by 11.16% to 9533.0 shares with purchase of 957.0 shares. This fresh investment now brings its stake to 0.07% valued currently at $1678.0. With over 13.61 million Sonoma […]
Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) Is Getting Increasingly Hard To Ignore
Tower Research Capital LLC recently announced the acquisition of new stake in Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA). The institutional investor has increased its shareholding in the Healthcare company by 11.16% to 9533.0 shares with purchase of 957.0 shares. This fresh investment now brings its stake to 0.18% valued currently at $1554.0. In addition, Wells Fargo Bank, […]
